Ovarian C4161001

Study #C4161001

Phase 1/2A Dose Escalation, Finding and Expansion Study Evaluation Safety Tolerability, Pharmacokinetics, Pharmacodynamics and Anti Tumor Activity of PF-07104091 as a Single Agent and in Combination Therapy